Literature DB >> 19531803

Suppression of LPS-induced TNF-alpha production in macrophages by cAMP is mediated by PKA-AKAP95-p105.

Estelle A Wall1, Joelle R Zavzavadjian, Mi Sook Chang, Baljinder Randhawa, Xiaocui Zhu, Robert C Hsueh, Jamie Liu, Adrienne Driver, Xiaoyan Robert Bao, Paul C Sternweis, Melvin I Simon, Iain D C Fraser.   

Abstract

The activation of macrophages through Toll-like receptor (TLR) pathways leads to the production of a broad array of cytokines and mediators that coordinate the immune response. The inflammatory potential of this response can be reduced by compounds, such as prostaglandin E(2), that induce the production of cyclic adenosine monophosphate (cAMP). Through experiments with cAMP analogs and multigene RNA interference (RNAi), we showed that key anti-inflammatory effects of cAMP were mediated specifically by cAMP-dependent protein kinase (PKA). Selective inhibitors of PKA anchoring, time-lapse microscopy, and RNAi screening suggested that differential mechanisms of PKA action existed. We showed a specific role for A kinase-anchoring protein 95 in suppressing the expression of the gene encoding tumor necrosis factor-alpha, which involved phosphorylation of p105 (also known as Nfkb1) by PKA at a site adjacent to the region targeted by inhibitor of nuclear factor kappaB kinases. These data suggest that crosstalk between the TLR4 and cAMP pathways in macrophages can be coordinated through PKA-dependent scaffolds that localize specific pools of the kinase to distinct substrates.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19531803      PMCID: PMC2770900          DOI: 10.1126/scisignal.2000202

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  75 in total

Review 1.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  SCF(beta)(-TrCP) ubiquitin ligase-mediated processing of NF-kappaB p105 requires phosphorylation of its C-terminus by IkappaB kinase.

Authors:  A Orian; H Gonen; B Bercovich; I Fajerman; E Eytan; A Israël; F Mercurio; K Iwai; A L Schwartz; A Ciechanover
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

3.  beta-adrenergic agonists exert their "anti-inflammatory" effects in monocytic cells through the IkappaB/NF-kappaB pathway.

Authors:  P Farmer; J Pugin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-10       Impact factor: 5.464

4.  Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit nuclear factor-kappa B-dependent gene activation at multiple levels in the human monocytic cell line THP-1.

Authors:  M Delgado; D Ganea
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

5.  Short communication: differences between macrophages and dendritic cells in the cyclic AMP-dependent regulation of lipopolysaccharide-induced cytokine and chemokine synthesis.

Authors:  David M Aronoff; Jennifer K Carstens; Gwo-Hsiao Chen; Galen B Toews; Marc Peters-Golden
Journal:  J Interferon Cytokine Res       Date:  2006-11       Impact factor: 2.607

6.  The use of RNA interference to analyze protein phosphatase function in mammalian cells.

Authors:  Iain Fraser; Wei Liu; Robert Rebres; Tamara Roach; Joelle Zavzavadjian; Leah Santat; Jamie Liu; Estelle Wall; Marc Mumby
Journal:  Methods Mol Biol       Date:  2007

7.  A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression.

Authors:  Kum-Joo Shin; Estelle A Wall; Joelle R Zavzavadjian; Leah A Santat; Jamie Liu; Jong-Ik Hwang; Robert Rebres; Tamara Roach; William Seaman; Melvin I Simon; Iain D C Fraser
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-31       Impact factor: 11.205

Review 8.  Negative regulators of toll-like receptor 4-mediated macrophage inflammatory response.

Authors:  Jonathan P Butchar; Kishore V L Parsa; Clay B Marsh; Susheela Tridandapani
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

9.  A fourth IkappaB protein within the NF-kappaB signaling module.

Authors:  Soumen Basak; Hana Kim; Jeffrey D Kearns; Vinay Tergaonkar; Ellen O'Dea; Shannon L Werner; Chris A Benedict; Carl F Ware; Gourisankar Ghosh; Inder M Verma; Alexander Hoffmann
Journal:  Cell       Date:  2007-01-26       Impact factor: 41.582

10.  Specificity and mechanism of action of some commonly used protein kinase inhibitors.

Authors:  S P Davies; H Reddy; M Caivano; P Cohen
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

View more
  96 in total

1.  Coxiella burnetii alters cyclic AMP-dependent protein kinase signaling during growth in macrophages.

Authors:  Laura J MacDonald; Richard C Kurten; Daniel E Voth
Journal:  Infect Immun       Date:  2012-04-02       Impact factor: 3.441

2.  Distinct roles of adenylyl cyclase VII in regulating the immune responses in mice.

Authors:  Biyan Duan; Richard Davis; Eva L Sadat; Julie Collins; Paul C Sternweis; Dorothy Yuan; Lily I Jiang
Journal:  J Immunol       Date:  2010-05-26       Impact factor: 5.422

3.  Anti-inflammatory effects of benfotiamine are mediated through the regulation of the arachidonic acid pathway in macrophages.

Authors:  Mohammad Shoeb; Kota V Ramana
Journal:  Free Radic Biol Med       Date:  2011-10-24       Impact factor: 7.376

4.  PTEN directly activates the actin depolymerization factor cofilin-1 during PGE2-mediated inhibition of phagocytosis of fungi.

Authors:  C Henrique Serezani; Steve Kane; Alexandra I Medeiros; Ashley M Cornett; Sang-Hoon Kim; Mariana Morato Marques; Sang-Pyo Lee; Casey Lewis; Emilie Bourdonnay; Megan N Ballinger; Eric S White; Marc Peters-Golden
Journal:  Sci Signal       Date:  2012-02-07       Impact factor: 8.192

5.  Neuropeptide PACAP in mouse liver ischemia and reperfusion injury: immunomodulation by the cAMP-PKA pathway.

Authors:  Haofeng Ji; Yu Zhang; Xiu-da Shen; Feng Gao; Cynthia Y Huang; Catalina Abad; Ronald W Busuttil; James A Waschek; Jerzy W Kupiec-Weglinski
Journal:  Hepatology       Date:  2013-01-18       Impact factor: 17.425

6.  G2A Protects Mice against Sepsis by Modulating Kupffer Cell Activation: Cooperativity with Adenosine Receptor 2b.

Authors:  Hong-Mei Li; Ji Hye Jang; Jun-Sub Jung; Jiseon Shin; Chul O Park; Yeon-Ja Kim; Won-Gyun Ahn; Ju-Suk Nam; Chang-Won Hong; Jongho Lee; Yu-Jin Jung; Jiang-Fan Chen; Katya Ravid; H Thomas Lee; Won-Ki Huh; Janusz H Kabarowski; Dong-Keun Song
Journal:  J Immunol       Date:  2018-12-10       Impact factor: 5.422

7.  Exogenous ceramide-1-phosphate (C1P) and phospho-ceramide analogue-1 (PCERA-1) regulate key macrophage activities via distinct receptors.

Authors:  Sebastián Katz; Orna Ernst; Dorit Avni; Muhammad Athamna; Amir Philosoph; Lide Arana; Alberto Ouro; L Alexis Hoeferlin; Michael M Meijler; Charles E Chalfant; Antonio Gómez-Muñoz; Tsaffrir Zor
Journal:  Immunol Lett       Date:  2015-12-03       Impact factor: 3.685

8.  Distinct PKA regulatory subunits mediate PGE2 inhibition of TGFβ-1-stimulated collagen I translation and myofibroblast differentiation.

Authors:  Scott H Wettlaufer; L Raghu Penke; Katsuhide Okunishi; Marc Peters-Golden
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-07-20       Impact factor: 5.464

9.  Pharmacological properties of ASP7657, a novel, potent, and selective prostaglandin EP4 receptor antagonist.

Authors:  Kazuhiko Mizukami; Hiroaki Kamada; Hiroyuki Yoshida; Ikuko Ishii; Eisuke Nozawa; Koichi Wada; Tohru Ugawa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-08-03       Impact factor: 3.000

10.  PGE(2) induces macrophage IL-10 production and a regulatory-like phenotype via a protein kinase A-SIK-CRTC3 pathway.

Authors:  Kirsty F MacKenzie; Kristopher Clark; Shaista Naqvi; Victoria A McGuire; Gesa Nöehren; Yosua Kristariyanto; Mirjam van den Bosch; Manikhandan Mudaliar; Pierre C McCarthy; Michael J Pattison; Patrick G A Pedrioli; Geoff J Barton; Rachel Toth; Alan Prescott; J Simon C Arthur
Journal:  J Immunol       Date:  2012-12-14       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.